Come up with a name for your new list and we'll add to it:
Ferrokin Biosciences was acquired by
Shire on March 19, 2012.
FerroKin BioSciences is focused on the development of medicines used to manage iron for the treatment of disease. The company is currently developing a new treatment for transfusional iron overload. I…